Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
Anolin Aslan, Cynthia Aslan, Naime Majidi Zolbanin, et al.
Pneumonia (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions
Valentina Carlini, Douglas M. Noonan, Eslam Abdalalem, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 157
Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers
Sang-Ryul Cha, Jimin Jang, Sung‐Min Park, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1210-1210
Open Access | Times Cited: 33
Engineered Polymer–siRNA Polyplexes Provide Effective Treatment of Lung Inflammation
Taewon Jeon, David C. Luther, Ritabrita Goswami, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 4315-4326
Open Access | Times Cited: 24
Computational lung modelling in respiratory medicine
Sunder Neelakantan, Yi Xin, Donald P. Gaver, et al.
Journal of The Royal Society Interface (2022) Vol. 19, Iss. 191
Open Access | Times Cited: 35
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study
Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 34
A Review of the Phytochemistry and Pharmacology of the Fruit of Siraitia grosvenorii (Swingle): A Traditional Chinese Medicinal Food
Juanjiang Wu, Yuqing Jian, Huizhen Wang, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6618-6618
Open Access | Times Cited: 31
An important call: Suggestion of using IL-10 as therapeutic agent for COVID-19 with ARDS and other complications
Li‐Jane Shih, Chun‐Chun Yang, Min-Tser Liao, et al.
Virulence (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Microneedle technology for potential SARS-CoV-2 vaccine delivery
Megan McNamee, Shuyi Wong, Owen J. Guy, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 6, pp. 799-814
Open Access | Times Cited: 17
COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
Ramona Cioboată, Viorel Biciușcă, Mihai Olteanu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4784-4784
Open Access | Times Cited: 17
Simultaneous Targeting of IL-1–Signaling and IL-6–Trans-Signaling Preserves Human Pulmonary Endothelial Barrier Function During a Cytokine Storm—Brief Report
Natalia Colás-Algora, Pablo Muñoz-Pinillos, Cristina Cacho-Navas, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 11, pp. 2213-2222
Closed Access | Times Cited: 15
Sea Cucumber and Blueberry Extracts Suppress Inflammation and Reduce Acute Lung Injury through the Regulation of NF-κB/MAPK/JNK Signaling Pathway in Lipopolysaccharide-Treated C57BL/6 Mice
Oladapo F. Fagbohun, Wasitha P. D. W. Thilakarathna, Juan Zhou, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1511-1511
Open Access | Times Cited: 5
SOCIO-EPIDEMIOLOGICAL PROFILE AND EFFECTS OF LONG-COVID-19 ON POST-PANDEMIC PATIENTS FROM SOUTHERN BRAZIL
Alencar Kolinski Machado
Aracê. (2025) Vol. 7, Iss. 1, pp. 977-995
Closed Access
Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral Hospital
Virginia Di Bari, Carlotta Cerva, Raffaella Libertone, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 1, pp. 11-11
Open Access
COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis
Roland Linder, Jonas Peltner, A. Astvatsatourov, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
The ZNF717-rs2918520 genotype contributes to COVID-19 severity: a Taiwanese cohort study
Yang-Hsiang Lin, Jen Yu, Yu-Chuan Teng, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Nanoparticles of Natural Product-derived Medicines: Beyond the Pandemic
Yedi Herdiana
Heliyon (2025) Vol. 11, Iss. 4, pp. e42739-e42739
Open Access
Quercetin inhibits steroid-induced hypergluconeogenesis in Saccharomyces cerevisiae
Victor Arokia Doss, G. Subramaniam, Karthikeyan Manoharan
Future Journal of Pharmaceutical Sciences (2025) Vol. 11, Iss. 1
Open Access
Drugs for COVID-19: An Update
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8562-8562
Open Access | Times Cited: 23
Anti-inflammatory and antioxidant activities of Gymnema Sylvestre extract rescue acute respiratory distress syndrome in rats via modulating the NF-κB/MAPK pathway
Aruna Jangam, Satya Krishna Tirunavalli, Bala Manikantha Adimoolam, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 823-844
Open Access | Times Cited: 13
Multiplex Lithographic SERS Aptasensor for Detection of Several Respiratory Viruses in One Pot
В. И. Кукушкин, Oganes Ambartsumyan, A. Yu. Subekin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8081-8081
Open Access | Times Cited: 13
Evaluation of various blood biomarkers associated with the outcomes of patients with COVID‑19 treated in intensive care units
Sıdıka Genç, Ali Taghizadehghalehjoughi, Muhammet Emin Naldan, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 2
Open Access | Times Cited: 4
Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched study
Shahin Isha, Prasanth Balasubramanian, Abby Hanson, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Interstitial Lung Fibrosis Following COVID-19 Pneumonia
Mihai Lazăr, Ecaterina Constanța Barbu, Cristina Emilia Chițu, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 2028-2028
Open Access | Times Cited: 20
A comparison of impact of comorbidities and demographics on 60-day mortality in ICU patients with COVID-19, sepsis and acute respiratory distress syndrome
Björn Ahlström, Robert Frithiof, Ing‐Marie Larsson, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome
Qinqin Fei, Emily M. Shalosky, Ryelie Barnes, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16539-16552
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top